SAM
BPMC

Sectoral Asset Management’s Blueprint Medicines BPMC Stock Holding History

Sectoral Asset Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,235
Closed -$994K – 96
2025
Q1 		$994K Sell
11,235
-1,325
-11% -$129K 0.77% 36
2024
Q4 		$1.1M Sell
12,560
-2,360
-16% -$216K 0.73% 39
2024
Q3 		$1.38M Buy
14,920
+11,070
+288% +$1.1M 0.82% 39
2024
Q2 		$415K Sell
3,850
-560
-13% -$56.1K 0.17% 71
2024
Q1 		$418K Buy
4,410
+1,940
+79% +$166K 0.16% 76
2023
Q4 		$228K Sell
2,470
-163,420
-99% -$10.6M 0.1% 98
2023
Q3 		$8.33M Buy
165,890
+29,053
+21% +$1.55M 1.62% 17
2023
Q2 		$8.65M Buy
136,837
+14,937
+12% +$812K 1.44% 22
2023
Q1 		$5.48M Buy
121,900
+6,000
+5% +$270K 1.05% 39
2022
Q4 		$5.08M Buy
115,900
+6,000
+5% +$288K 0.98% 45
2022
Q3 		$7.24M Buy
109,900
+28,000
+34% +$1.8M 1.43% 24
2022
Q2 		$4.14M Hold
81,900
– – 0.83% 51
2022
Q1 		$5.23M Buy
81,900
+16,100
+24% +$1.16M 0.93% 41
2021
Q4 		$7.05M Buy
+65,800
New +$6.88M 1.06% 38
2021
Q1 		– Sell
-136,500
Closed -$15.3M – 118
2020
Q4 		$15.3M Sell
136,500
-158,233
-54% -$16.7M 1.08% 37
2020
Q3 		$27.3M Buy
294,733
+4,150
+1% +$320K 2.35% 8
2020
Q2 		$22.7M Buy
+290,583
New +$19.7M 2.08% 9
2020
Q1 		– Sell
-45,000
Closed -$3.6M – 67
2019
Q4 		$3.6M Buy
+45,000
New +$3.37M 0.54% 50
2019
Q3 		– Sell
-10,984
Closed -$1.04M – 67
2019
Q2 		$1.04M Buy
10,984
+6,800
+163% +$561K 0.12% 67
2019
Q1 		$335K Hold
4,184
– – 0.04% 82
2018
Q4 		$226K Hold
4,184
– – 0.03% 83
2018
Q3 		$327K Buy
+4,184
New +$291K 0.03% 104

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sectoral Asset Management's BPMC Position: Q2 2025 in Review

Sectoral Asset Management sold out of Blueprint Medicines (BPMC) in Q2 2025, closing a stake of 11,235 shares — an estimated $994K sold.

Sectoral Asset Management first reported a position in BPMC in Q3 2018 and held it in 22 quarters. The position peaked at $27.3M in Q3 2020. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.

  • Sectoral Asset Management reported no remaining Blueprint Medicines position as of Q2 2025 after selling out during the quarter.
  • Sectoral Asset Management sold 11,235 Blueprint Medicines shares in Q2 2025, an estimated $994K.
  • Sectoral Asset Management first reported a position in Blueprint Medicines in Q3 2018 and held it in 22 quarters.
  • Sectoral Asset Management's Blueprint Medicines position peaked at $27.3M in Q3 2020.
  • 354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.

Based on Sectoral Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.